Predicting liver transplant outcomes with scoring tools
Part of Digestive system clinical trials.
This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 60 years old.
- You must have cirrhosis of the liver, no matter the cause.
- You must be eligible for a liver transplant and listed for one.
- You must not have acute liver failure without cirrhosis or other transplant contraindications.
- You must not have conditions like hepatopulmonary syndrome or refractory ascites that require exceptional MELD scores.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares new scoring tools to predict outcomes in people with liver cirrhosis who are hospitalized for sudden worsening (like fluid buildup, confusion, or bleeding). It aims to find which score works best to guide care.
This trial is testing new scoring systems to better predict how patients with acute-on-chronic liver failure will do. It may help doctors make more informed treatment decisions for people with this serious liver condition.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study looks at a prediction tool that estimates outcomes for people with liver cancer and cirrhosis, to help decide whether a liver transplant is a good option. It may help doctors choose the right timing and patients who could benefit most from transplantation.
This study develops a tool to predict which liver transplant patients might develop infections after surgery. By identifying high-risk patients early, doctors could provide extra monitoring or preventive care to improve outcomes.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.